Nanotech offers big cure for human diseases

Nanotech offers big cure for human diseases
Think of the medicin­es you take each time. Have you ever thought of the dosage of medicine you consume and how much of it is actually reaching the targetted body part.

You take a medicine orally for a specific ailment. A lot of it will get distributed to places within the body where it is unwanted leading to toxicity and other side effects. Now, if there is a mechanism to improve the efficiency of the drug delivery then there will be an overall reduction in the do­se administered. Nanotechnol­ogy offers a solution to this problem. It holds a great potential for better healthcare by introducing the way for more efficient drug usage, thus bringing down the cost of healthcare substantially.

Present research in the applic­ation of nanotechnology in biomedical sciences at the Centre for Research in Nanot­echnology and Science at Indian Institute of Technology, Bombay, promises huge hopes to people suffering from cancer, heart diseases, tuberculosis, respiratory distress syndrome and arthritis. From early detection of heart disease to designing nanoparticles as carriers of drugs to improve the efficacy of drug administration; from embedding smart sensors in human body to monitor vital analysts to developing nanoparticles of biological origin to overcome several anatomical barriers incl­uding the ‘blood brain barrier’; there is huge potential of nanotechnology to treat diseases.

Rinti Banerjee, professor of biomedical engineering at IIT Bombay and a member of CRNTS, is heading a group of researchers who are exploring a wide range of possibilities in using nanotechnology to address diseases like cancer, pneumonia, TB, arthr­itis. Ba­nerjee and her team are developing nanoparticles for each of these diseases.

“We have developed nanoparticle which are given in the form of aerosols for respiratory distress syndrome. These aerosols are capable of reaching deeper parts of lungs,” said Banerjee.

The group has made significant inve­stigations and development in the anti-cancer area. “Lots of works are on in lung cancer and colon cancer,” she said. According to Banerj­ee, in the ca­se of cancer, most drugs have substantial toxic effects. So nanote­ch can allow the drug to go specifically to the cancer site.

It was the concept of tattooing that inspired Rohit Srivastava, as­sistant professor at IIT Bombay, to look at nanoscale sensors and act­uators to monitor human body and cure all its ills. His work will involve integrating nanotechnology with tissue engineering and bi­osensing and can be easily ext­en­ded to monitoring the effects of drugs, especially the release of immunomodulating agents.

Recently scientific journal Na­ture reported about US resea­rchers developing a tiny nanoparticle robot that can travel through a patient’s blood and into tumo­urs where they deliver therapy th­at turns off an important cancer gene. Scientists believe that it is an early proof that a new treatme­nt approach called RNA (ribonucleic acid) interference or RNAi might work in people. Do­zens of biotechnology and pharmaceutic­al firms are looking for ways to manipulate RNA to block genes that make disease-causing prote­ins involved in cancer or AIDS.

There is also hope for osteoart­hritis patients. The research is on to develop nano-sized smart mat­erials that, when injected, would support tissue regeneration.

According to her, there are also efforts to look at things, which will go through the skin. Like a patch on the surface of the skin, which is loaded with nanoparticl­es and that can penetrate thro­ugh the layers of the skin and then go into the tissue. For joints, you can directly place it on the surface of the joint.

While Banerjee confirmed that some of the technologies are bei­ng transferred to industry, she declined to gi­ve details on account of co­nfidentiality cl­auses. “I would be optimistic about the anticancer nanoparticles for lung ca­ncer and colon ca­ncer,” she added.

There are also new inventions supported by nanotechnology in diagnostic tools. V Ramgopal Rao from the department of electrical engineering in IIT Bombay has created a cardiac diagnostic kit using nanotechnology for early detection of myocardial infarction from a drop of your blood. Called ‘iSens’, it comprises a tabletop box and a disposable slide with fi­elds that changes colour depending on the condition of the heart.

“ECG is the most common way to find the health of human hea­rt. Early detection of heart attack is possible with this because there are certain elements in blood like protein that needs to be monitor­ed and iSens is capable of doing that,” said Rao. He says nanoelectro mechanical systems identifies nano motions from the blood sa­mple and converts them into ele­ctric signals which can be identif­ied from the top box. While it is one more way to diagnose, Rao said the kit will considerably red­uce the lab bills and results are quick.

Earlier Rao was part of a team that developed a portable silicon locket, a device for continuous monitoring of the heart. The locket will allow patients at high risk of cardiac arrest to wirelessly mo­nitor the heart. When an irregularity in heartbeat, or arrhythmia occurs, using a mobile phone in­terface, the locket can automatic­ally transmit through SMS the la­st few seconds of the ECG data to a central server. Tata Consultancy Services, which funded the re­search, will market the device.

Nanomedicine based on nanotechnology holds immense scope in diagnosis and treatment of cancer and Parkinsons, according to experts. “The technology could be successfully used to diagnose and treat oral cancer,” said Shanti Nair, director of the Centre for Nano Sciences of the Amrita Viswa Vidya Peetham University in Kochi.

Post new comment

E-mail ID will not be published
CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.

EDITORIAL OF THE DAY

  • Bureaucrats have enjoyed flying miles at taxpayer expense for too long

    The beleaguered Indian taxpayer will certainly applaud prime minister Narendra Modi’s attempt to deliver on his promise of cutting down fiscal defic

FC NEWSLETTER

Stay informed on our latest news!

INTERVIEWS

GV Nageswara Rao

MD & CEO, IDBI Federal Life

Timothy Moe

Goldman Sachs

Chander Mohan Sethi

CMD, Reckitt Benckiser India

COLUMNIST

Varun Dutt

<b>Riskfactor</b>: CHAIN REACTION

A domino effect is the cumulative effect produced when one ...

Zehra Naqvi

Rememberance and forgetting are crucial

Memories are so vital to our lives that they can ...

Dharmendra Khandal

Sandalwood may get extinct if not protected

When we talk of sandalwood, the most common usage that ...

INTERVIEWS

William D. Green

Chairman & CEO, Accenture